- Home
- ZCAR vs SNSE Comparison
ZCAR vs SNSE Comparison
Compare ZCAR & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCAR
- SNSE
- Stock Information
- Founded
- ZCAR 2013
- SNSE 2005
- Country
- ZCAR India
- SNSE United States
- Employees
- ZCAR N/A
- SNSE N/A
- Industry
- ZCAR Blank Checks
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- ZCAR Finance
- SNSE Health Care
- Exchange
- ZCAR Nasdaq
- SNSE Nasdaq
- Market Cap
- ZCAR 11.6M
- SNSE 12.5M
- IPO Year
- ZCAR N/A
- SNSE 2021
- Fundamental
- Price
- ZCAR $0.52
- SNSE $0.45
- Analyst Decision
- ZCAR
- SNSE Strong Buy
- Analyst Count
- ZCAR 0
- SNSE 3
- Target Price
- ZCAR N/A
- SNSE $4.33
- AVG Volume (30 Days)
- ZCAR 1.7M
- SNSE 169.4K
- Earning Date
- ZCAR 02-14-2025
- SNSE 03-03-2025
- Dividend Yield
- ZCAR N/A
- SNSE N/A
- EPS Growth
- ZCAR N/A
- SNSE N/A
- EPS
- ZCAR N/A
- SNSE N/A
- Revenue
- ZCAR $9,117,419.00
- SNSE N/A
- Revenue This Year
- ZCAR N/A
- SNSE N/A
- Revenue Next Year
- ZCAR N/A
- SNSE N/A
- P/E Ratio
- ZCAR N/A
- SNSE N/A
- Revenue Growth
- ZCAR N/A
- SNSE N/A
- 52 Week Low
- ZCAR $0.50
- SNSE $0.38
- 52 Week High
- ZCAR $183.00
- SNSE $1.94
- Technical
- Relative Strength Index (RSI)
- ZCAR 29.79
- SNSE 38.52
- Support Level
- ZCAR $1.12
- SNSE $0.44
- Resistance Level
- ZCAR $1.74
- SNSE $0.49
- Average True Range (ATR)
- ZCAR 0.19
- SNSE 0.04
- MACD
- ZCAR -0.00
- SNSE -0.00
- Stochastic Oscillator
- ZCAR 1.93
- SNSE 10.73
About ZCAR Zoomcar Holdings Inc.
Zoomcar Holdings Inc is India's largest marketplace for cars on rent. Zoomcar is a leading emerging-market-focused peer-to-peer car-sharing marketplace, with approximately 21,000 vehicles registered through its platform. The Company derives its revenue principally from short-term self-drive rentals and vehicle subscriptions. The self-drive rental business generates the majority of revenue. Geographically The company operates in India, Egypt, Indonesia, Vietnam, and the Philippines, Out of which the majority of revenue is derived from India.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.